Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
暂无分享,去创建一个
K. Kalunian | G. Illei | M. Khamashta | J. Merrill | R. Furie | V. Werth | J. Drappa | Liangwei Wang | W. Greth